Is Amarin Corporation PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Amarin Corporation PLC (AMRN) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Amarin Corporation PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Amarin Corporation PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Amarin Corporation PLC?

Muslim investors may consider investing in Amarin Corporation PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Amarin Corporation PLC classified as NOT HALAL?

Musaffa determines the Shariah status of Amarin Corporation PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Amarin Corporation PLC updated?

The Shariah compliance status of Amarin Corporation PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Amarin Corporation PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Amarin Corporation PLC?

You can check the latest Shariah compliance status of Amarin Corporation PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AMRN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 04, 2026

Report Source: 2026 1st Quarter Report

Amarin Corporation PLC. Stock Analysis AMRN

United States Health Care Micro Cap Report: Q1, 2026

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The firm operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Key Statistics of Amarin Corporation PLC (AMRN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$14.24$15.24

Today's Open

$14.67

Volume

55.90K

P/E Ratio (TTM)

52 Week Range

$9.98$20.90

Market Cap

298.75M

Avg. Volume

82.25K

Dividend Yield

Financial Metrics & Statements of Amarin Corporation PLC (AMRN)

FAQ's for Amarin Corporation PLC (AMRN)

According to Musaffa’s Shariah screening methodology, Amarin Corporation PLC (AMRN) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.